Skip to main content

Advertisement

SpringerLink
Log in

Current status of organ transplantation in Japan and worldwide

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Recent advances in immunosuppressant therapy have dramatically reduced the frequency of acute rejection of organ transplants. Subsequently, the short-term graft survival rate has been improved, and ABO blood type-incompatible and existing anti-HLA antibody-positive kidney transplantation has been enabled, which has increased the availability of living kidney donors. Japan has a unique history and strategies of liver transplantation (LT) for various liver diseases. The outcomes of living donor liver transplantation (LDLT) in Japan is comparable to that of deceased donor liver transplantation (DDLT) in Western countries despite the relatively short history of LT. The main disadvantage of LT in Japan is donor shortage mainly due to the small number of available deceased donors. There are some disadvantages with LDLT in autoimmune liver diseases because of the dependence on blood relative donors. The first brain-dead pancreas transplantation (PTx) was performed in 2000. Since that time, 42 brain-dead PTx, 2 non-heart beating PTx, and 14 living donor PTx had been performed by the end of 2007. One of the 44 recipients of deceased donor PTx died of unknown causes 11 months after transplantation. Although most of the deceased donors in Japan were marginal and their condition was not favorable, the results of these cases were comparable to those of Western countries. Fourteen intestinal transplantations (ITx) had been performed by the end of 2007 in four transplant centers. There were 3 deceased donor and 11 live donor transplants. The original diseases included short bowel syndrome (n = 6), intestinal function disorder (n = 6), and retransplantation (n = 2). The graft and patient survival rate are 60% and 69%, respectively. Eight recipients survived and stopped parenteral nutrition with full-functioning grafts. Amendment of the Japanese law for the utilization of deceased donors should increase the number available donors in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Takahashi K, Saito K. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation 2006;13:118–122.

    Article  PubMed  Google Scholar 

  2. The Japan Society for Transplantation. Organ Transplantation Factbook 2008. http//www.asas.or.jp/jst/factbook/2008/index.html.

  3. Kadotani Y, Okamoto M, Akioka K, Ushigome H, Ogino S, Nobori S, et al. Management and outcome of living kidney grafts with multiple arteries. Surg Today 2005;35:459–466.

    Article  PubMed  Google Scholar 

  4. Yoshimura N, Okamoto M, Akioka K, Kaihara S. Optimization of the use of cyclosporine in renal transplantation. Transplant Proc 2004;36:181–185.

    Article  CAS  Google Scholar 

  5. Yoshimura N, Akioka K, Ushigome H, Kadotani Y, Ogino S, Wakabayashi Y, et al. Twenty-five-year survival of living related kidney transplants: thirty-five years’ experience. Transplant Proc 2005;37:687–689.

    Article  PubMed  CAS  Google Scholar 

  6. Okamoto M, Akioka K, Higuchi A, Kadotani Y, Ushigome H, Uryuhara K, et al. Clinicopathological evaluation of renal allograft treated with anti-CD25 monoclonal antibody. Clin Transplant 2005;19:49–53.

    Article  PubMed  Google Scholar 

  7. The Japanese Society for Clinical Renal Transplantation. Annual progress report from the Japanese Renal Transplant Registry: number of renal transplantations in 2007. Ishoku 2009;42:414–422.

    Google Scholar 

  8. Okamoto M, Omori Y, Ichida M, Nobori S, Higuchi A, Kadotani Y, et al. An autopsy case of bacterial septic shock 12 years following ABO-incompatible renal transplantation. Clin Transplant 2004;18:44–49.

    Article  PubMed  Google Scholar 

  9. Starzl TE, Marchioro TL, Von Kaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in human. Surg Gynecol Obstet 1963;117:659–676.

    PubMed  CAS  Google Scholar 

  10. Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB, et al. Orthotopic homotransplantations of the human liver. Ann Surg 1968;168:392–415.

    Article  PubMed  CAS  Google Scholar 

  11. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation form a living donor to her son. N Engl J Med 1990;322:1505–1507.

    Article  PubMed  CAS  Google Scholar 

  12. Registry by the Japanese Liver Transplantation Society 2008. Ishoku 2008;43:458–469.

    Google Scholar 

  13. Organ Procurement and Transplantation Network (OPTN)/Scientific Registry of Transplant Recipients (SRTR). Annual Report in USA, European Liver Transplant Registry (ELTR) Report.

  14. Gordon Burroughs S, Busuttil RW. Optimal utilization of extended hepatic grafts. Surg Today 2009;39:746–751.

    Article  PubMed  Google Scholar 

  15. Watashi K, Hijikata M, Hosaka M, Yamaji M, Shimotohno K. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003;38:1282–1288.

    Article  PubMed  CAS  Google Scholar 

  16. Berenguer M, Prieto M, Palau A, Carrasco D, Rayón JM, Calvo F, et al. Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon-ribavirin therapy. Eur J Gastroenterol Hepatol 2004;16:1207–1212.

    Article  PubMed  CAS  Google Scholar 

  17. Sugawara Y, Kaneko J, Makuuchi M. Cyclosporin A for treatment of hepatitis C virus after liver transplantation. Transplantation 2006;82:579–580.

    Article  PubMed  CAS  Google Scholar 

  18. Firpi RJ, Zhu H, Morelli G, Abdelmalek MF, Soldevila-Pico C, Machicao VI, et al. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl 2006;12:51–57.

    Article  PubMed  Google Scholar 

  19. Hasegawa K, Kokudo N. Surgical treatment of hepatocellular carcinoma. Surg Today 2009;39:833–843.

    Article  PubMed  Google Scholar 

  20. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765–774.

    Article  PubMed  Google Scholar 

  21. Silva M, Moya A, Berenguer M, Sanjuan F, López-Andujar R, Pareja E, et al. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 2008;14:1449–1460.

    Article  PubMed  Google Scholar 

  22. Ito T, Takada Y, Ueda M, Haga H, Maetani Y, Oike F, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007;13:1637–1644.

    Article  PubMed  Google Scholar 

  23. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007;25:310–312.

    Article  PubMed  Google Scholar 

  24. Milkiewicz P. Liver transplantation in primary biliary cirrhosis. Clin Liver Dis 2008;12:461–472.

    Article  PubMed  Google Scholar 

  25. Rowe IA, Webb K, Gunson BK, Mehta N, Haque S, Neuberger J. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transpl Int 2008;21:459–465.

    Article  PubMed  Google Scholar 

  26. Sanchez EQ, Levy MF, Goldstein RM, Fasola CG, Tillery GW, Netto GJ, et al. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 2003;76:1583–1588.

    Article  PubMed  Google Scholar 

  27. Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Transplant Proc 2005;37:1691–1692.

    Article  PubMed  CAS  Google Scholar 

  28. Morioka D, Egawa H, Kasahara M, Jo T, Sakamoto S, Ogura Y, et al. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007;13:80–90.

    Article  PubMed  Google Scholar 

  29. Gautam M, Cheruvattath R, Balan V. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006;12:1813–1824.

    Article  PubMed  Google Scholar 

  30. Maheshwari A, Yoo HY, Thuluvath PJ. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol 2004;99:538–542.

    Article  PubMed  Google Scholar 

  31. Egawa H, Taira K, Teramukai S, Haga H, Ueda Y, Yonezawa A, et al. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience. Dig Dis Sci 2009;54:1347–1354.

    Article  PubMed  Google Scholar 

  32. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967;61:827–837.

    PubMed  CAS  Google Scholar 

  33. Kuo PC, Wong J, Schweitzer EJ, Johnson LB, Lim JW, Bartlett ST. Outcome after splenic vein thrombosis in the pancreas allograft. Transplantation 1997;64:933–935.

    Article  PubMed  CAS  Google Scholar 

  34. Gilabert R, Fernández-Cruz L, Real MI, Ricart MJ, Astudillo E, Montaña X. Treatment and outcome of pancreatic venous graft thrombosis after kidney-pancreas transplantation. Br J Surg 2002;89:355–360.

    Article  PubMed  CAS  Google Scholar 

  35. Ciancio G, Cespedes M, Olson L, Miller J, Burke GW. Partial venous thrombosis of the pancreatic allografts after simultaneous pancreas-kidney transplantation. Clin Transplant 2000;14:464–471.

    Article  PubMed  CAS  Google Scholar 

  36. Delis S, Dervenis C, Bramis J, Burke GW, Miller J, Ciancio G. Vascular complications of pancreas transplantation. Pancreas 2004;28:413–420.

    Article  PubMed  Google Scholar 

  37. Nghiem DD. Pancreatic allograft thrombosis: diagnostic and therapeutic importance of splenic venous flow velocity. Clin Transplant 1995;9:390–395.

    PubMed  CAS  Google Scholar 

  38. Ciancio G, Julian JF, Fernandez L, Miller J, Burke GW. Successful surgical salvage of pancreas allografts after complete venous thrombosis. Transplantation 2000;70:126–131.

    PubMed  CAS  Google Scholar 

  39. Maraschio MA, Kayler LK, Merion RM, Rudich SM, Punch JD, Magee JC, et al. Successful surgical salvage of partial pancreatic allograft thrombosis. Transplant Proc 2003;35:1491–1493.

    Article  PubMed  CAS  Google Scholar 

  40. Zhou W, Choi L, Lin PH, Dardik A, Eraso A, Lumsden AB. Percutaneous transhepatic thrombectomy and pharmacologic thrombolysis of mesenteric venous thrombosis. Vascular 2007;15:41–45.

    Article  PubMed  Google Scholar 

  41. Kim HS, Patra A, Khan J, Arepally A, Streiff MB. Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis. J Vasc Interv Radiol 2005;16:1685–1691.

    PubMed  Google Scholar 

  42. Okamoto M, Suzuki T, Fujiki M, Nobori S, Ushigome H, Sakamoto S, et al. A rare case of functional pancreas graft with newly developed collateral venous drainage after complete portal thrombosis. Transpl Int 2009;22:763–765.

    Article  PubMed  Google Scholar 

  43. Yoshimatsu R, Yamagami T, Terayama K, Matsumoto T, Miura H, Nishimura T, et al. Percutaneous transcatheter thrombolysis for graft thrombosis after pancreas transplantation. Pancreas 2009;38:597–599.

    Article  PubMed  Google Scholar 

  44. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005;19:433–455.

    Article  PubMed  Google Scholar 

  45. Singh RP, Stratta RJ. Advances in immunosuppression for pancreas transplantation. Curr Opin Organ Transplant 2008;13:79–84.

    Article  PubMed  Google Scholar 

  46. Salvalaggio PR, Davies DB, Fernandez LA, Kaufman DB. Outcomes of pancreas transplantation in the United States using cardiac-death donors. Am J Transplant 2006;6(5 Pt 1):1059–1065.

    Article  PubMed  CAS  Google Scholar 

  47. Gruessner RW, Sutherland DE, Drangstveit MB, Bland BJ, Gruessner AC. Pancreas transplants from living donors: short- and long-term outcome. Transplant Proc 2001;33:819–820.

    Article  PubMed  CAS  Google Scholar 

  48. Tojimbara T, Teraoka S, Babazono T, Sato S, Nakamura M, Hoshino T, et al. Long-term outcome after combined pancreas and kidney transplantation from non-heart-beating cadaver donors Transplant Proc 1998;30:3793–3794.

    Article  PubMed  CAS  Google Scholar 

  49. The Japanese Society for Pancreas and Islet Transplantation. The Registry of Japanese Pancreas Transplantation 2008. Jpn J Transplant 2008;43:477–481.

    Google Scholar 

  50. Abu-Elmagd KM, Bond G, Reyes J, Fung J. Intestinal transplantation: a coming of age. Adv Surg 2002;6:65–101.

    Google Scholar 

  51. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 1968;64:134–142.

    PubMed  CAS  Google Scholar 

  52. Medicare Coverage Policy Decisions, Intestinal and multivisceral transplantation. CAG-00036, October 4, 2000.

  53. Gruessner RW, Sharp HL. Living-related intestinal transplantation: first report of a standardized surgical technique. Transplantation 1997;11:271–274.

    Google Scholar 

  54. Abu-Elmagd KM: Intestinal transplantation: Indications and patient selection. In: Langnas AN, Goulet O, Quigley EMM, Tappenden KA, editors. Intestinal failure. Malden, MA: Blackwell; 2008. 245–253.

    Google Scholar 

  55. Abu-Elmagd K, Reyes J, Bond G, Mazariegos G, Wu T, Murase N, et al. Clinical intestinal transplantation: a decade of a single center experience. Ann Surg 2001;234:404–417.

    Article  PubMed  CAS  Google Scholar 

  56. Kato T, O’Brein CB, Nishida S, Hoppe H, Gasser M, Berho M, et al. The first case report of the use of a zoom videoendoscope for the evaluation of small bowel graft mucosa in a human after intestinal transplantation. Gastrointest Endosc 1999;50:257–261.

    Article  PubMed  CAS  Google Scholar 

  57. Lee RG, Nakamura K, Tsamandas AC, Abu-Elmagd K, Furukawa H, Hutson WR, et al. Pathology of human intestinal transplantation. Gastroenterology 1996;110:1820–1834.

    Article  PubMed  CAS  Google Scholar 

  58. Intestinal Transplant Registry: http//www.intestinaltransplant.org/.

  59. Grant D, Abu-Elmagd K, Reyes J, Tzakis A, Langnas A, Fishbein T, et al. 2003 Report of the intestinal transplant registry: a new era has dawned. Ann Surg 2005;241:607–613.

    Article  PubMed  Google Scholar 

  60. Sudan D. Cost and quality of life after intestinal transplantation. Gastroenterology 2006;130:S158–S162.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Organ Transplant and Regenerative Surgery, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 465 Hirokoji Kawaramachi, Kamigyo-ku, Kyoto, 602-0841, Japan

    Norio Yoshimura, Hideaki Okajima, Hidetaka Ushigome, Seisuke Sakamoto, Masato Fujiki & Masahiko Okamoto

  2. Department of Organ Interaction Research Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan

    Norio Yoshimura, Masato Fujiki & Masahiko Okamoto

  3. Department of Transplant Surgery, National Center for Child Health and Development, Tokyo, Japan

    Seisuke Sakamoto

  4. Department of General Surgery, Cleveland Clinic, Transplantation Center, Cleveland, OH, USA

    Masato Fujiki

Authors
  1. Norio Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideaki Okajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hidetaka Ushigome
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seisuke Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masato Fujiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masahiko Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshimura, N., Okajima, H., Ushigome, H. et al. Current status of organ transplantation in Japan and worldwide. Surg Today 40, 514–525 (2010). https://doi.org/10.1007/s00595-009-4214-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-009-4214-3

Key words

Search

Navigation